EMA Considers Product Development Stage For Complying With ICH Guide On Bioanalytical Method Validation
Executive Summary
The European Medicines Agency has drafted a plan to address specific issues that drug companies may face when it comes to complying with the International Council for Harmonisation’s M10 guideline.